Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu multicentrická studie, časopisecké články, práce podpořená grantem
PubMed
36351814
PubMed Central
PMC9969910
DOI
10.1212/wnl.0000000000201537
PII: WNL.0000000000201537
Knihovny.cz E-zdroje
- MeSH
- cerebrální krvácení komplikace MeSH
- cévní mozková příhoda * epidemiologie terapie diagnóza MeSH
- COVID-19 * komplikace MeSH
- endovaskulární výkony * škodlivé účinky MeSH
- fibrinolytika terapeutické užití MeSH
- intrakraniální krvácení etiologie MeSH
- ischemická cévní mozková příhoda * epidemiologie chirurgie MeSH
- ischemie mozku * komplikace epidemiologie chirurgie MeSH
- kohortové studie MeSH
- lidé MeSH
- registrace MeSH
- trombolytická terapie škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fibrinolytika MeSH
BACKGROUND AND OBJECTIVES: COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19. METHODS: This was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT). RESULTS: Of a total of 15,128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19; of those, 5,848 (38.7%) patients received IVT-only and 9,280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted OR 1.53; 95% CI 1.16-2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20-2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23-1.99), 24-hour mortality (OR 2.47; 95% CI 1.58-3.86), and 3-month mortality (OR 1.88; 95% CI 1.52-2.33). Patients with COVID-19 also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26-1.60). DISCUSSION: Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 patients receiving treatment. Current available data do not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in patients with COVID-19 or to establish different treatment recommendations in this subgroup of patients with ischemic stroke. Our findings can be taken into consideration for treatment decisions, patient monitoring, and establishing prognosis. TRIAL REGISTRATION INFORMATION: The study was registered under ClinicalTrials.gov identifier NCT04895462.
1th Department of Neurology Institute of Psychiatry and Neurology Warsaw Poland
2nd Department of Neurology Institute of Psychiatry and Neurology Warsaw Poland
Ain Shams University Affiliated Saudi German Hospital Egypt
Alexandria University Hospitals and Affiliated Stroke Network Egypt
Center for Health Research Faculty of Medicine University of Ostrava Czech Republic
Centro de Investigaciones Clínicas Fundación Valle del Lili Cali Colombia
Cerebrovascular Centre Central Military Hospital Prague Czech Republic
Cerebrovascular Centre General University Hospital Prague Czech Republic
Cerebrovascular Centre Na Homolce Hospital Prague Czech Republic
Cerebrovascular Centre University Hospital in Motol Prague Czech Republic
Clinic of Neurology Military Institute of Medicine Warsaw Poland
Department of Clinical and Experimental Sciences Neurology Clinic University of Brescia Italy
Department of Clinical Therapeutics National and Kapodistrian University of Athens Greece
Department of Interventional and Diagnostic Neuroradiology Bordeaux University Hospital France
Department of Interventional Neuroradiology Hôpital Fondation Ade Rothschild Paris France
Department of Neurology Amsterdam University Medical Centers Netherlands
Department of Neurology and Stroke Centre Madrid Spain
Department of Neurology and Stroke Spain
Department of Neurology and Stroke St John Paul 2 Western Hospital Grodzisk Mazowiecki Poland
Department of Neurology and Stroke Unit Azienda Socio Sanitaria Territoriale Lecco Italy
Department of Neurology ASST Papa Giovanni XXIII Bergamo Italy
Department of Neurology Centre Hospitalier Universitaire de Charleroi Belgium
Department of Neurology Centro Hospitalar de Vila Nova de Gaia Espinho Portugal
Department of Neurology Centro Hospitalar Universitário de Coimbra Portugal
Department of Neurology Centro Hospitalar Universitário do Porto Portugal
Department of Neurology Centro Hospitalar Universitário São João Porto Portugal
Department of Neurology České Budějovice Hospital Czech Republic
Department of Neurology Complejo Hospitalario Universitario de Albacete
Department of Neurology Comprehensive Stroke Centre Hospital Clinic from Barcelona Spain
Department of Neurology Eskisehir Osmangazi University Turkey
Department of Neurology Fundación Valle del Lili Cali Colombia
Department of Neurology Grant Medical College and Sir JJ Hospital Mumbai India
Department of Neurology Henry Ford Hospital Detroit MI
Department of Neurology Hôpital Fondation Ade Rothschild Paris France
Department of Neurology Hospital de Egas Moniz Centro Hospitalar Lisboa Ocidental Lisbon Portugal
Department of Neurology Hospital Garcia de Orta Almada Portugal
Department of Neurology Hospital Nacional Edgardo Rebagliati Martins EsSalud Lima Péru
Department of Neurology Hospital Nossa Senhora da Conceição Hospital Porto Alegre Brazil
Department of Neurology Hospital Universitario Virgen Macarena Seville Spain
Department of Neurology Ibn Sina Hospital Kuwait
Department of Neurology Institute of Medical Sciences Medical College of Rzeszow University Poland
Department of Neurology Institute of Medical Sciences University of Opole Poland
Department of Neurology Jaber Al Ahmad Hospital Kuwait
Department of Neurology Jihlava Hospital Czech Republic
Department of Neurology Karviná Miners Hospital Inc Czech Republic
Department of Neurology National Health Insurance Service Ilsan Hospital Goyang Korea
Department of Neurology Policlinico Universitario Agostino Gemelli Rome Italy
Department of Neurology Radiology Boston Medical Center Boston University School of Medicine MA
Department of Neurology School of Medicine Zanjan University of Medical Sciences Iran
Department of Neurology St John's Hospital Vienna Austria
Department of Neurology Stroke Unit Europe Hospitals Brussels Belgium
Department of Neurology Unidade Local de Saúde de Matosinhos Portugal
Department of Neurology University Hospital Frankfurt Goethe University Germany
Department of Neurology University Hospital Jagiellonian University Cracow Poland
Department of Neurology University Hospital of Zurich Switzerland
Department of Neurology University of Arkansas for Medical Sciences Little Rock AR
Department of Neurology University of Kansas Medical Centre
Department of Neurology University of Warmia and Mazury Olsztyn Poland
Department of Neurology Upstate University Hospital NY
Department of Neurology Wayne State University Detroit Medical Center MI
Department of Neuroradiology Centro Hospitalar de Vila Nova de Gaia Espinho Portugal
Department of Neuroradiology Centro Hospitalar Universitário de Coimbra Portugal
Department of Neuroradiology Centro Hospitalar Universitário São João Porto Portugal
Department of Neuroradiology Charité Universitätsmedizin Berlin Germany
Department of Neuroradiology Geneva University Hospital Switzerland
Department of Neurosurgery Thomas Jefferson University Hospital PA
Department of Radiology Provincial Specialist Hospital Olsztyn Poland
Department of Radiology University Emergency Hospital Bucharest Romania
Departments of Neurology Hospital de Braga Portugal
Departments of Neurology Medical University of Innsbruck Austria
Departments of Neurology Wroclaw Medical University Poland
Departments of Radiology Neurology and Neurosurgery Grady Memorial Hospital Atlanta GA
Emergency Neurology and Stroke Unit IRCCS Humanitas Clinical and Research Center Rozzano Italy
Endovascular Neurological Surgery and Neurology Rutgers The State University of New Jersey Newark
Hospital General San Juan de Dios Guatemala
Neurocenter Regional Hospital Liberec Czech Republic
Neurology Department Leuven University Hospital Belgium
Neurology Stroke Unit Centre Hospitalier Universitaire Grenoble Alpes France
Neurology Unit Stroke Unit Azienda Unità Sanitaria IRCCS di Reggio Emilia Italy
Neuropsychiatry Department Tanta University Egypt
Neuroradiology Unit Azienda Unità Sanitaria IRCCS di Reggio Emilia Italy
Ramos Mejía Hospital Stroke Unit Buenos Aires Argentina
School of Biomedical Engineering and Imaging Sciences St Thomas Hospital King's College London UK
St Luke's Medical Center Global City Philippines
Stroke and Geriatric Medicine Aintree University Hospital United Kingdom
Stroke Center Neurocenter of Southern Switzerland EOC Lugano
Stroke Centre Geneva University Hospital Switzerland
Stroke Centre Hirslanden Hospital Zurich Switzerland
Stroke Centre Hospital General Universitario Gregorio Marañón Madrid Spain
Stroke Centre Kantonsspital Lucerne Switzerland
Stroke Centre University Hospital Basel and University of Basel Switzerland
Stroke Unit Azienda Ospedaliera Universitaria Integrata Verona Italy
Stroke Unit Department of Neurology Hospital Universitario Miguel Servet Spain
Stroke Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
Stroke Unit Germans Trias Hospital Barcelona Spain
Stroke Unit Hospital de São José Centro Hospitalar Universitário Lisboa Central Lisbon Portugal
Stroke Unit Neurology Department Hillel Yaffe Medical Center Hadera Israel
University College London Queen Square Institute of Neurology London United Kingdom
Zobrazit více v PubMed
Mao L, Jin H, Wang M, et al. . Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. PubMed PMC
Sashindranath M, Nandurkar HH. Endothelial dysfunction in the brain: setting the stage for stroke and other cerebrovascular complications of COVID-19. Stroke. 2021;52(5):1895-1904. PubMed PMC
Sagris D, Papanikolaou A, Kvernland A, et al. . COVID-19 and ischemic stroke. Eur J Neurol. 2021;28(11):3826-3836. PubMed PMC
Mbonde AA, O'Carroll CB, Grill MF, Zhang N, Butterfield R, Demaerschalk BM. Stroke features, risk factors, and pathophysiology in SARS-CoV-2-infected patients. Mayo Clinic Proc Innov Qual Outcomes. 2022;6(2):156-165. PubMed PMC
Ntaios G, Michel P, Georgiopoulos G, et al. . Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry. Stroke. 2020;51(9):e254–e258. PubMed PMC
Dhamoon MS, Thaler A, Gururangan K, et al. . Acute cerebrovascular events with COVID-19 infection. Stroke. 2021;52(1):48-56. PubMed
Perry RJ, Smith CJ, Roffe C, et al. . Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry. 2021;92(3):242-248. PubMed
Srivastava PK, Zhang S, Xian Y, et al. . Acute ischemic stroke in patients with COVID-19: an analysis from get with the guidelines-stroke. Stroke. 2021;52(5):1826-1829. PubMed
Fuentes B, Alonso de Leciñana M, García-Madrona S, et al. . Stroke acute management and outcomes during the COVID-19 outbreak: a cohort study from the madrid stroke network. Stroke. 2021;52(2):552-562. doi: 10.1161/strokeaha.120.031769 PubMed DOI
Strambo D, De Marchis GM, Bonati LH, et al. . Ischemic stroke in COVID‐19 patients: mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis. Eur J Neurol. 2022;29(3):732-743. PubMed PMC
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (covid- 19): a Review. JAMA. 2020;324(8):782-793. PubMed
Escalard S, Maïer B, Redjem H, et al. . Treatment of acute ischemic stroke due to large vessel occlusion with COVID-19: experience from paris. Stroke. 2020;51(8):2540-2543. PubMed PMC
Pezzini A, Grassi M, Silvestrelli G, et al. . Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network. J Neurol. 2021;268(10):3561-3568. PubMed PMC
Cappellari M, Zini A, Sangalli D, et al. . Thrombolysis and bridging therapy in patients with acute ischaemic stroke and COVID-19. Eur J Neurol. 2020;27(12):2641-2645. PubMed
Sasanejad P, Afshar Hezarkhani L, Arsang-Jang S, et al. . Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19: CASCADE initiative. J Stroke Cerebrovasc Dis. 2021;30(12):106121. doi: 10.1016/j.jstrokecerebrovasdis.2021.106121 PubMed DOI PMC
Pop R, Hasiu A, Bolognini F, et al. . Stroke thrombectomy in patients with COVID-19: initial experience in 13 cases. AJNR Am J Neuroradiol. 2020;41(11):2012-2016. PubMed PMC
Wang A, Mandigo GK, Yim PD, Meyers PM, Lavine SD. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics. J NeuroInterv Surg. 2020;12(7):648-653. PubMed
Cagnazzo F, Piotin M, Escalard S, et al. . European multicenter study of ET-COVID-19. Stroke. 2021;52(1):31-39. PubMed
European Centre for Disease Prevention and Control. 2021. Surveillance Definitions for COVID-19. ecdc.europa.eu/en/covid-19/surveillance/surveillance-definitions
WHO COVID-19 Case Definition. 2021. who.int/publications/i/item/WHO-2019-nCoV- Surveillance_Case_Definition-2020.2
Hacke W, Kaste M, Fieschi C, et al. . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245-1251. PubMed
Zaidat OO, Castonguay AC, Linfante I, et al. . First pass effect: a new measure for stroke thrombectomy devices. Stroke. 2018;49(3):660-666. PubMed
Zetterqvist J, Sjölander A. Doubly robust estimation with the R package drgee. Epidemiologic Methods. 2015;4(1):69-86.
Buuren Sv, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1-67.
Barda N, Dagan N, Ben-Shlomo Y, et al. . Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078-1090. PubMed PMC
Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, et al. . Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism. Blood. 2016;128(20):2423-2434. PubMed
Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, et al. . Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089-3103. PubMed PMC
Tiainen M, Meretoja A, Strbian D, et al. . Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients. Int J Stroke. 2013;8:632-638. PubMed
Consoli D, Vidale S, Arnaboldi M, et al. . Infections and Chlamydia pneumoniae antibodies influence the functional outcome in thrombolysed strokes. J Neurol Sci. 2017;381:95-99. PubMed
Maslias E, Nannoni S, Ricciardi F, et al. . Procedural complications during early versus late endovascular treatment in acute stroke: frequency and clinical impact. Stroke. 2021;52(3):1079-1082. PubMed
Fischer U. On behalf of the Improving Reperfusion strategies in Ischemic Stroke (IRIS) working group investigators, Direct mechanical thrombectomy versus bridging therapy—cumulative study-level meta-analysis of the DIRECT-MT, MR CLEAN-NOIV, DEVT, SKIP AND SWIFT-DIRECT Randomized Clinical Trials. Eur Stroke J. 2021;6(1S):514. PubMed
ClinicalTrials.gov
NCT04895462